• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性疟原虫:在重组痘苗病毒感染的细胞中对传播阻断疫苗候选物Pfs48/45进行异源合成。

Plasmodium falciparum: heterologous synthesis of the transmission-blocking vaccine candidate Pfs48/45 in recombinant vaccinia virus-infected cells.

作者信息

Milek R L, DeVries A A, Roeffen W F, Stunnenberg H, Rottier P J, Konings R N

机构信息

Department of Molecular Biology, University of Nijmegen, Toernooiveld 1, Nijmegen, 6525 ED, The Netherlands.

出版信息

Exp Parasitol. 1998 Oct;90(2):165-74. doi: 10.1006/expr.1998.4315.

DOI:10.1006/expr.1998.4315
PMID:9769246
Abstract

With the aim of developing transmission-blocking vaccines based on the sexual stage-specific surface antigen Pfs48/45 of the human malaria parasite Plasmodium falciparum, the gene encoding Pfs48/45 was incorporated into the genome of a recombinant vaccinia virus. In virus-infected mammalian tissue culture cells, recombinant Pfs48/45 antigen (rPfs48/45) is posttranslational modified to produce a highly N-glycosylated polypeptide. The rPfs48/45 protein was radiolabeled with ethanolamine, consisting of a further posttranslational modification in the form of a glycosylphosphatidylinositol anchor at its carboxy-terminal end. The rPfs48/45 was not detected on the surface of the infected cells; instead, it remained within the secretion pathway of mammalian cells irrespective of the duration of infection or culture temperature. Studies with monoclonal antibodies specific for disulfide band-dependent epitopes of Pfs48/45 revealed that recombinant Pfs48/45 is not folded in its authentic conformation even if N-glycosylation was chemically inhibited. Infection of mice and rabbits with recombinant virus elicited Pfs48/45-specific antibodies; however, the antisera failed to block parasite transmission in a standard mosquito membrane-feeding assay.

摘要

为了开发基于人类疟原虫恶性疟原虫有性阶段特异性表面抗原Pfs48/45的传播阻断疫苗,将编码Pfs48/45的基因整合到重组痘苗病毒的基因组中。在病毒感染的哺乳动物组织培养细胞中,重组Pfs48/45抗原(rPfs48/45)经过翻译后修饰,产生高度N-糖基化的多肽。rPfs48/45蛋白用乙醇胺进行放射性标记,在其羧基末端以糖基磷脂酰肌醇锚的形式进行进一步的翻译后修饰。在感染细胞的表面未检测到rPfs48/45;相反,无论感染持续时间或培养温度如何,它都保留在哺乳动物细胞的分泌途径中。对Pfs48/45的二硫键依赖性表位具有特异性的单克隆抗体研究表明,即使化学抑制N-糖基化,重组Pfs48/45也不会折叠成其真实构象。用重组病毒感染小鼠和兔子可引发Pfs48/45特异性抗体;然而,在标准的蚊媒膜饲实验中,抗血清未能阻断寄生虫传播。

相似文献

1
Plasmodium falciparum: heterologous synthesis of the transmission-blocking vaccine candidate Pfs48/45 in recombinant vaccinia virus-infected cells.恶性疟原虫:在重组痘苗病毒感染的细胞中对传播阻断疫苗候选物Pfs48/45进行异源合成。
Exp Parasitol. 1998 Oct;90(2):165-74. doi: 10.1006/expr.1998.4315.
2
Immune responses in mice induced by prime-boost schemes of the Plasmodium falciparum apical membrane antigen 1 (PfAMA1)-based DNA, protein and recombinant modified vaccinia Ankara vaccines.基于恶性疟原虫顶端膜抗原1(PfAMA1)的DNA、蛋白质和重组改良安卡拉痘苗疫苗的初免-加强免疫方案在小鼠中诱导的免疫反应。
Vaccine. 2006 Sep 11;24(37-39):6187-98. doi: 10.1016/j.vaccine.2006.05.099. Epub 2006 Jun 12.
3
[Cloning and sequencing of the gene coding the sexual stage antigen Pfs48/45 of Plasmodium falciparum].[恶性疟原虫有性阶段抗原Pfs48/45编码基因的克隆与测序]
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 1998;16(6):406-10.
4
Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.一种重组疟疾候选疫苗(恶性疟原虫AMA-1胞外结构域的I+II结构域,来自印度恶性疟原虫等位基因)的免疫原性。
Vaccine. 2008 Aug 18;26(35):4526-35. doi: 10.1016/j.vaccine.2008.06.031. Epub 2008 Jun 30.
5
Heterologous expression of the C-terminal antigenic domain of the malaria vaccine candidate Pfs48/45 in the green algae Chlamydomonas reinhardtii.在绿藻莱茵衣藻中异源表达疟疾候选疫苗抗原 PfS48/45 的 C 末端抗原结构域。
Appl Microbiol Biotechnol. 2013 Mar;97(5):1987-95. doi: 10.1007/s00253-012-4071-7. Epub 2012 May 18.
6
A Plasmodium falciparum candidate vaccine based on a six-antigen polyprotein encoded by recombinant poxviruses.一种基于重组痘病毒编码的六抗原多聚蛋白的恶性疟原虫候选疫苗。
Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):290-5. doi: 10.1073/pnas.0307158101. Epub 2003 Dec 23.
7
An efficient approach to the production of vaccines against the malaria parasite.一种生产抗疟原虫疫苗的有效方法。
Methods Mol Biol. 2010;607:73-83. doi: 10.1007/978-1-60327-331-2_8.
8
A potent malaria transmission blocking vaccine based on codon harmonized full length Pfs48/45 expressed in Escherichia coli.一种基于在大肠杆菌中表达的密码子优化全长Pfs48/45的高效疟疾传播阻断疫苗。
PLoS One. 2009 Jul 22;4(7):e6352. doi: 10.1371/journal.pone.0006352.
9
Improving the malaria transmission-blocking activity of a Plasmodium falciparum 48/45 based vaccine antigen by SpyTag/SpyCatcher mediated virus-like display.通过SpyTag/SpyCatcher介导的病毒样展示提高基于恶性疟原虫48/45的疫苗抗原的疟疾传播阻断活性。
Vaccine. 2017 Jun 27;35(30):3726-3732. doi: 10.1016/j.vaccine.2017.05.054. Epub 2017 May 31.
10
Plasmodium falciparum: production and characterization of rat monoclonal antibodies specific for the sexual-stage Pfs48/45 antigen.
Exp Parasitol. 2001 Jan;97(1):45-9. doi: 10.1006/expr.2000.4586.

引用本文的文献

1
A combined designed CSP and Pfs48/45 infection and transmission blocking vaccine for malaria.一种用于疟疾的联合设计的CSP和Pfs48/45感染及传播阻断疫苗。
NPJ Vaccines. 2025 Sep 2;10(1):208. doi: 10.1038/s41541-025-01262-2.
2
Targeting Bottlenecks in Malaria Transmission: Antibody-Epitope Descriptions Guide the Design of Next-Generation Biomedical Interventions.针对疟疾传播的瓶颈:抗体-表位描述指导下一代生物医学干预措施的设计。
Immunol Rev. 2025 Mar;330(1):e70001. doi: 10.1111/imr.70001.
3
Plasmodium falciparum serology: A comparison of two protein production methods for analysis of antibody responses by protein microarray.
恶性疟原虫血清学:两种蛋白生产方法在蛋白微阵列分析抗体反应中的比较。
PLoS One. 2022 Aug 29;17(8):e0273106. doi: 10.1371/journal.pone.0273106. eCollection 2022.
4
Immunity against sexual stage Plasmodium falciparum and Plasmodium vivax parasites.针对疟原虫和间日疟原虫有性阶段寄生虫的免疫力。
Immunol Rev. 2020 Jan;293(1):190-215. doi: 10.1111/imr.12828. Epub 2019 Dec 16.
5
A Plant-Produced in vivo deglycosylated full-length Pfs48/45 as a Transmission-Blocking Vaccine Candidate against malaria.一种植物源性体内去糖基化全长 PfS48/45 作为疟疾传播阻断候选疫苗。
Sci Rep. 2019 Jul 8;9(1):9868. doi: 10.1038/s41598-019-46375-6.
6
Fusion to Tetrahymena thermophila granule lattice protein 1 confers solubility to sexual stage malaria antigens in Escherichia coli.与嗜热四膜虫颗粒晶格蛋白1融合可使疟原虫有性阶段抗原在大肠杆菌中具有溶解性。
Protein Expr Purif. 2019 Jan;153:7-17. doi: 10.1016/j.pep.2018.08.001. Epub 2018 Aug 3.
7
Expression of full-length Plasmodium falciparum P48/45 in P. berghei blood stages: A method to express and evaluate vaccine antigens.恶性疟原虫P48/45全长蛋白在伯氏疟原虫血液阶段的表达:一种表达和评估疫苗抗原的方法。
Mol Biochem Parasitol. 2018 Sep;224:44-49. doi: 10.1016/j.molbiopara.2018.07.009. Epub 2018 Jul 24.
8
In vivo production of non-glycosylated recombinant proteins in Nicotiana benthamiana plants by co-expression with Endo-β-N-acetylglucosaminidase H (Endo H) of Streptomyces plicatus.通过与褶皱链霉菌的内切-β-N-乙酰氨基葡萄糖苷酶H(Endo H)共表达,在本氏烟草植物中体内生产非糖基化重组蛋白。
PLoS One. 2017 Aug 21;12(8):e0183589. doi: 10.1371/journal.pone.0183589. eCollection 2017.
9
Construct design, production, and characterization of Plasmodium falciparum 48/45 R0.6C subunit protein produced in Lactococcus lactis as candidate vaccine.在乳酸乳球菌中产生的恶性疟原虫48/45 R0.6C亚基蛋白作为候选疫苗的构建设计、生产及特性分析
Microb Cell Fact. 2017 May 31;16(1):97. doi: 10.1186/s12934-017-0710-0.
10
Immunogenicity and malaria transmission reducing potency of Pfs48/45 and Pfs25 encoded by DNA vaccines administered by intramuscular electroporation.通过肌肉内电穿孔接种的DNA疫苗所编码的Pfs48/45和Pfs25的免疫原性及降低疟疾传播的效力
Vaccine. 2017 Jan 5;35(2):264-272. doi: 10.1016/j.vaccine.2016.11.072. Epub 2016 Nov 29.